[1]
Haidar Mohammed Hussein and Ali Abdulhussein Kasim 2025. Correlation of the Complement Decay Accelerating Factor, Tumour Necrosis Factors-alpha, and Interleukin-1 Beta with the Response to Rituximab in Rheumatoid Arthritis Patients. Iraqi Journal of Pharmaceutical Sciences . 33, (4SI) (Feb. 2025), 222–229. DOI:https://doi.org/10.31351/vol33iss(4SI)pp222-229.